The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Steven E. Lipshultz

Department of Pediatrics

University of Miami Miller School of Medicine


FL 33101


Name/email consistency: high



  • Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101. 2005 - 2012
  • Department of Pediatrics, University of Miami School of Medicine, Holtz Children's Hospital of the University of Miami/Jackson Memorial Medical Center and the Sylvester Comprehensive Cancer Center, Miami 33101, USA. 2004 - 2008
  • Department of Cardiology, Harvard Medical School, Boston, USA. 2006
  • Department of Community and Preventive Medicine, The University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 2005
  • University of Miami, Department of Pediatrics, PO Box 016820 (D820), Miami, USA. 2003


  1. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Lipshultz, S.E., Miller, T.L., Lipsitz, S.R., Neuberg, D.S., Dahlberg, S.E., Colan, S.D., Silverman, L.B., Henkel, J.M., Franco, V.I., Cushman, L.L., Asselin, B.L., Clavell, L.A., Athale, U., Michon, B., Laverdière, C., Schorin, M.A., Larsen, E., Usmani, N., Sallan, S.E. Pediatrics (2012) [Pubmed]
  2. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. Lipshultz, S.E., Landy, D.C., Lopez-Mitnik, G., Lipsitz, S.R., Hinkle, A.S., Constine, L.S., French, C.A., Rovitelli, A.M., Proukou, C., Adams, M.J., Miller, T.L. J. Clin. Oncol. (2012) [Pubmed]
  3. Changes in cardiac biomarkers during Doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. Lipshultz, S.E., Miller, T.L., Scully, R.E., Lipsitz, S.R., Rifai, N., Silverman, L.B., Colan, S.D., Neuberg, D.S., Dahlberg, S.E., Henkel, J.M., Asselin, B.L., Athale, U.H., Clavell, L.A., Laverdière, C., Michon, B., Schorin, M.A., Sallan, S.E. J. Clin. Oncol. (2012) [Pubmed]
  4. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). Lipshultz, S.E., Shearer, W.T., Thompson, B., Rich, K.C., Cheng, I., Orav, E.J., Kumar, S., Pignatelli, R.H., Bezold, L.I., LaRussa, P., Starc, T.J., Glickstein, J.S., O'Brien, S., Cooper, E.R., Wilkinson, J.D., Miller, T.L., Colan, S.D. J. Am. Coll. Cardiol. (2011) [Pubmed]
  5. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lipshultz, S.E., Scully, R.E., Lipsitz, S.R., Sallan, S.E., Silverman, L.B., Miller, T.L., Barry, E.V., Asselin, B.L., Athale, U., Clavell, L.A., Larsen, E., Moghrabi, A., Samson, Y., Michon, B., Schorin, M.A., Cohen, H.J., Neuberg, D.S., Orav, E.J., Colan, S.D. Lancet Oncol. (2010) [Pubmed]
  6. Clinical research directions in pediatric cardiology. Lipshultz, S.E., Wilkinson, J.D., Messiah, S.E., Miller, T.L. Curr. Opin. Pediatr. (2009) [Pubmed]
  7. Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns. Lipshultz, S.E., Simbre, V.C., Hart, S., Rifai, N., Lipsitz, S.R., Reubens, L., Sinkin, R.A. Am. J. Cardiol. (2008) [Pubmed]
  8. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Lipshultz, S.E., Alvarez, J.A., Scully, R.E. Heart (2008) [Pubmed]
  9. Heart failure in childhood cancer survivors. Lipshultz, S.E. Nature Clinical Practice. Oncology (2007) [Pubmed]
  10. Frequency of clinically unsuspected myocardial injury at a children's hospital. Lipshultz, S.E., Wong, J.C., Lipsitz, S.R., Simbre, V.C., Zareba, K.M., Galpechian, V., Rifai, N. Am. Heart J. (2006) [Pubmed]
  11. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz, S.E. Semin. Oncol. (2006) [Pubmed]
  12. The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity. Lipshultz, S.E., Cohen, H., Colan, S.D., Herman, E.H. Leuk. Lymphoma (2006) [Pubmed]
  13. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. Lipshultz, S.E., Lipsitz, S.R., Sallan, S.E., Dalton, V.M., Mone, S.M., Gelber, R.D., Colan, S.D. J. Clin. Oncol. (2005) [Pubmed]
  14. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Adams, M.J., Lipshultz, S.E. Pediatr. Blood. Cancer (2005) [Pubmed]
  15. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Lipshultz, S.E., Vlach, S.A., Lipsitz, S.R., Sallan, S.E., Schwartz, M.L., Colan, S.D. Pediatrics (2005) [Pubmed]
  16. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. Lipshultz, S.E., Rifai, N., Dalton, V.M., Levy, D.E., Silverman, L.B., Lipsitz, S.R., Colan, S.D., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Gelber, R.D., Sallan, S.E. N. Engl. J. Med. (2004) [Pubmed]
  17. Cardiovascular Complications in Patients with HIV Infection. Zareba, K.M., Lipshultz, S.E. Curr. Infect. Dis. Rep (2003) [Pubmed]
WikiGenes - Universities